Intravitreal concentrations of some drugs administered with microdialysis

Acta Ophthalmologica Scandinavica

Volumn 75, Issue 1, 1997, Pages 36-40

  Waga, Janina ^a   Ehinger, Berndt ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 Fluorouracil; Benzyl penicillin; Daunomycin; Dexamethasone; Microdialysis; Vitreous

Indexed keywords

DAUNORUBICIN; DEXAMETHASONE; FLUOROURACIL; PENICILLIN G;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; INTRAVITREAL DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; VITREOUS BODY;

EID: 0030928877     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1997.tb00246.x     Document Type: Article

References (33)

1. Ames A & Nesbett FB (1981): In vitro retina as an experimental model of the central nervous system. J Neurochem 37: 867-77.
2. Becker B (1960): The transport of organic anions by the rabbit eye. I. In vitro iodopyracet (Diodrast) accumulation by ciliary bodyiris preparations. Am J Ophthalmol 50: 862-867.
3. Blumenkranz MS, Ophir A, Claflin AJ & Hajek A (1982): Fluorouracil for the treatment of massive periretinal proliferation. Am J Ophthalmol 94: 458-467.
4. Graham RO & Peyman GA (1974): Intravitreal injection of dexamethasone. Arch Ophthalmol 92: 149-54.
5. Jawetz E (1992): Penicillins & Cephalosporins. In: Katzung G, Apleton & Lange (eds). Basic & Clinical Pharmacology. East Norwalk.
6. Kawasaki K, Ohnogi J, Okayama Y & Yonemura D (1987): Effects of Antibiotics on the in vitro ERG of the albino rabbit. Doc Ophthalmol 66: 75-84.
7. Khawly JA, Saloupis P, Hatchell DL & Machemer R (1991): Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 229: 464-467.
8. Kirmani M, Santana M, Sorgente N, Wiedemann P & Ryan SJ (1983): Antiproliferative drugs in the treatment of experimental proliferative vitreoretinopathy. Retina 3: 269-272.
9. Kwak HW & D'Amico D J (1992): Evaluation of the retinal toxicity and pharmacokinetics of Dexamethasone after intravitreal injection. Arch Ophthalmol 110: 259-266.
10. Leon JA, Britt JM, Hopp RH & Milam AH (1990): Effects of Fluorouracil and Fluorouridine on protein Synthesis in Rabbit Retina. Invest Ophthalmol Vis Sci 31: 1709-1716.
11. Leopold IH (1945): Intravitreal penetration of penicillin therapy of infections of the vitreous. Arch Ophthalmol 33: 211-216.
12. Lindefors N, Amberg G & Ungerstedt U (1989): Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J Pharmacol Methods 22: 141-156.
13. Martin DF, Parks DJ, Mellow SD, Ferris FL, Walton RC, Remaley NA, Chew EY, Ashton P, Davis MD & Nussenblatt R B (1994): Treatment of cytomegalovirus retinitis with an intraocular sustained-release Ganciclovir implant. Arch Ophthalmol 112: 1531-1539.
14. Maxwell DP Jr, Brent BD, Diamond JG & Wu Leeteh (1991): Effect of Intravitreal Dexamethasone on Ocular Histopathology in a Rabbit Model of Endophthalmitis. Ophthalmology 98: 1370-1375.
15. McManaway JW, Weinberg RS & Coudron PE (1990): Coryneform Endophthalmitis. Two case reports. Arch Ophthalmol 108: 942-944.
16. Metrikin DC & Anand R (1994): Intravitreal drug administration with depot devices. Curr Opin Ophthalmol 5: 21-29.
17. Mietz H, Walshe R, Wiedemann P, Heimann K & Green WR (1994): Histopathologic study of epiretinal proliferations after vitrectomy with daunomycin and silicone oil. Retina 14: 425-429.
18. Nabih M, Peyman GA, Tawakol ME & Naguib K (1991): Toxicity of high-dose intravitreal dexamethasone. Int Ophthalmol 15: 233-235.
19. Ophir A (1991): Effects of 5-Fluorouracil on proliferating fibroblasts in vivo. Exp Brain Res 53: 799-803.
20. Paris CL, Peyman GA, Gremillion CM & Blinder KJ (1991): Intravitreal dexamethasone following vitreous. Int Ophthalmol 15: 173-174.
21. Polansky JR & Weinreb RN (1984): Anti-inflammatory agents: Steroids as Anti-Inflammatory Agents. In: Sears ML (ed). Pharmacology of the eye, pp 459-538. Springer Verlag, Berlin, Heidelberg.
22. Santana M, Wiedemann P, Kirmani M, Minckler DS, Patterson R, Sorgente N & Rya SJ (1984): Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit. Graefes Arch Clin Exp Ophthalmol 221: 210-213.
23. Schulman JA & Peyman GA (1992): Intravitreal corticosteroids as an adjunct in the treatment of bacterial and fungal endophthalmitis. Retina 12:336-340.
24. Sears ML (ed) (1984): Pharmacology of the eye. Springer-Verlag, Berlin, Heidelberg.
25. Stern WH, Guerin CJ, Erickson PA & Lewis GP (1983): Ocular toxicity of Fluorouracil after vitrectomy. Am J Ophthalmol 96: 43-51.
26. Ungerstedt U (1984): Measurement of Neurotransmitter release by Intracranial Dialysis. In: Marsden CA (ed). Measurement of Neurotransmitter Release in vivo, pp 81-104. John Wiley & Sons Ltd.
27. Waga J, Ohta A & Ehinger B (1991): Intraocular microdialysis with permanently implanted probes in rabbit. Acta Ophthalmol (Copenh): 69: 618-624.
28. Waga J & Ehinger B (1995): Passage of drugs through different intraocular microdialysis membranes. Graefes Arch Clin Exp Ophthalmol 233: 31-37.
29. Wiedemann P, Evans PY, Wiedemann R, Meyer-Schwickerath R & Heimann K (1989): A fluorescein angiographic study on patients with proliferative vitreoretinopathy treated by vitrectomy and intraocular daunomycin. Int Ophthalmol 13: 211-216.
30. Wiedemann P & Heimann K (1990): Toxicity of intraocular daunomycin. Lens and Eye Toxicity Research 7(3&4): 305-310.
31. Wiedemann R Lemmen K, Schmiedl R & Heimann K (1987): Intraocular Daunorubicin for the Treatment and Prophylaxis of Traumatic Proliferative Vitreoretinopathy. Am J Ophthalmol 104: 3-4.
32. Wiedemann P, Sorgente N, Bekhor C, Patterson R, Tran T & Ryan S J (1985): Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 26: 719-725.
33. Williams D J (1990): Antimicrobial substances. In: Linton AH & Dick HM (eds). Principles of Bacteriology, Virology and Immunity, pp 106-151. Edward Arnold, London.